Publicaciones

Glutamatergic Dysfunction in Schizophrenia: from basic neuroscience to clinical psychopharmacology

Fetal Alcohol Spectrum Disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model

Increased Expression of Activity-Dependent Genes in Cerebellar Glutamatergic Neurons of Patients With Schizophrenia

1. Labarca, R, Paz, R., R,. Inestroza, N.   “Depression and Alzheimer Disease” Capítulo VIII, pages 255 – 267. Tiempo nuevo para el adulto mayor, enfoque interdisciplinario. Edited by   Vice – Rectoría Académica de la Pontificia Universidad Católica de Chile.1994.

2. Paz, R  “Case Analysis: Ethics of Clinical Research and the Ethics of doctor-patient relationship” Capítulo X, pág. 318 – 330. Libro Etica Clínica Fundamentos y Aplicaciones. Ediciones Universidad Católica de Chile. 1993.

3. Lavados M., Mosso L. Paz R., “Doctor–Patient relationship in an outpatient service” Capítulo IV, pág. 970 – 101. Libro : “Etica Clínica. Fundamentos y Aplicaciones”. Ediciones Universidad Católica de Chile. 1993.

4. Paz R., Brokering W, Minoletti A., “Guidelines for the rational use of Clozapine”  Publicaciones Unidad de Salud Mental  Ministerio de Salud 2000.

5. Paz R., Doud S, Conley R., Roberts R., Bustillo J., Andreasen N., Perrone-Bizzozero N “Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia “  Am J Psychiatry. 2006;163:1829-31

6. Bustillo. J. Barrow. R., Paz, R , Perrone-Bizzozero. N., Bolognani F., Lauriello. J.,” Long Term Treatment of Rats with Haloperidol: Lack of an Effect on Brain N-acetyl aspartate Levels” Neuropsychopharmacology. 2006;31:751-6

7. Atzori. M.,Flores. J., Hernandez P., Paz, R  “Dopamine prevents muscarinic-induced decrease of glutamate release in the auditory cortex” Neuroscience. 2005;134:1153-65

8. Serani A., Paz R., Castillo A. “The ‘whole-animal approach’ as a heuristic principle in neuroscience research”  Biol Res. 2005;38:359-64

9. Paz R. “Schizophrenia pathophysiology from dopamine to glutamate, from glutamate to GABA”  Revista Chilena de Neuro-Psiquiatría, Diciembre 2005

10. Caldwell KK, Sheema S, Paz R, Samudio-Ruiz SL, Laughlin MH, Spence NE, Roehlk MJ, Alcon SN, Allan AM. Fetal alcohol spectrum disorder-associated depression: evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse model. Pharmacol Biochem Behav. 2008;90(4):614-24

11. Paz R, Barsness B. ,  Martenson T., Tanner D., Allan A.  “Behavioral teratogenicity induced by non-forced maternal nicotine consumption” Neuropsychopharmacology. 2007;32(3):693-9

12. Paz R, Tardito S, Atzori M, Tseng KY. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol. 2008;18(11):773-86

13. Paz R, Ortiz T, Cañive JM. Auditory gating deficits in schizophrenia: unimodal or heteromodal dysfunction? Actas Esp Psiquiatr. 2007;35 (3):208-18.

14. Smith A; Edgar C, Huang M, Lu B, Thoma R, Hanlon F,  McHaffie G, Aaron P, Jones A, Paz R,  Miller G, and Cañive J. Cognitive abilities and 50 and 100 ms paired-click processes in schizophrenia. American Journal of Psychiatry (In press)

15. Paz R, Sanguesa J, Bases neurobiológicas de la conducta antisocial en niños con Déficit Atencional Sección Psiquiatría Tratado de Pediatría Meneghello, (En prensa)